Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chronic Pain × Ketamine × Clear all

Phase

Phase NA 3 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 5 Neoplasms 5 Pain, Intractable 3 Agnosia 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Peripheral Nervous System Diseases 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain, Procedural 1 Neurotoxicity Syndromes 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Mucositis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Neutrophilic, Chronic 1

Interventions

Sodium Chloride 2 Tapentadol 1 Ropivacaine 1 Pregabalin 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Ketamine 1 Fentanyl 1 Educational Status 1 Anti-Inflammatory Agents, Non-Steroidal 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02303847 2015-05-27

Ketamine

University of Washington

Phase 3 Unknown

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡